Georgetown Lombardi Comprehensive Cancer Center

Type: Organization

Name: Georgetown Lombardi Comprehensive Cancer Center

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Preclinical tests shows agent stops 'slippery' proteins from binding, causing Ewing sarcoma

WASHINGTON — Continuous infusion of a novel agent not only halted the progression of Ewing sarcoma in rats, while some tumors also regressed to the point that cancer cells could not be detected microscopically, say researchers at Georgetown Lombardi Comprehensive ... [Published FierceBiotech - May 21 2013]

Entities: sarcoma, Cancer, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Protein

First reported May 17 2013 - Updated May 17 2013 - 2 reports

Preclinical tests shows agent stops 'slippery' proteins from binding, causing Ewing sarcoma

NCI Cancer Center News Continuous infusion of a novel agent not only halted the progression of Ewing sarcoma in rats, while some tumors also regressed to the point that cancer cells could not be detected microscopically, say researchers at Georgetown ... [Published National Cancer Institute - May 17 2013]

Entities: sarcoma, Cancer, Protein

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Initiation of breast cancer treatment varies by race; patient-doctor communication is key

(NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- WASHINGTON - Black women with breast cancer were found to be three times more likely than their white counterparts to delay treatment for more than 90 days - a time delay associated with ... [Published NewsRX - May 17 2013]

Entities: Breast Cancer, Chemotherapy, oncologist, Oncology

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Georgetown Receives PCORI Research Award to Study Latina Breast Cancer Survivorship

WASHINGTON— Georgetown Lombardi Comprehensive Cancer Centerhas received a research award from the Patient-Centered Outcomes Research Institute (PCORI) to study a quality-of-life intervention program targeting Latina breast cancer survivors and their caregivers. ... [Published Oncology Business Review - May 17 2013]

Entities: Cancer, Georgetown Lombardi Comprehensive Cancer Center, Breast Cancer, Georgetown University Medical Center, Patient

First reported May 16 2013 - Updated May 16 2013 - 1 reports

First prospective trial shows molecular profiling timely for tailoring therapy

WASHINGTON A clinical trial has shown that patients, and their physicians, are eager to jump into next-era cancer care analysis of an individual's tumor to find and target genetic mutations that drive the cancer. Results of the study, CUSTOM, are being ... [Published Bio-Medicine - May 16 2013]

Entities: Patient, Cancer, biopsy, Profiling

First reported May 15 2013 - Updated May 15 2013 - 2 reports

First prospective trial shows molecular profiling timely for tailoring therapy

Entities: mutations, Patient, Cancer

First reported May 14 2013 - Updated May 15 2013 - 1 reports

Angelina Jolie

For Breast Cancer,Testing And Surgery Costs Hard To Pin Down

WASHINGTON, DC (WUSA9) -- Angelina Jolie probably didn't worry about the costs of testing or surgery. But many women do.The prices for preventive mastectomy are all over the place. Several local hospitals declined to even answer questions about the c ... [Published WUSA 9 - May 14 2013]

Entities: Breast Cancer, Angelina Jolie, Georgetown Lombardi Comprehensive Cancer Center, prophylactic mastectomy, preventive mastectomy

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Patient Blogging Could Offer Host of Benefits

We share many aspects of our lives online, and illness is no exception. by the Pew Research Center's Internet & American Life Project, of the 74% of American adults using the Internet, 34% have read someone else's commentary or experience about health ... [Published IHealthBeat - May 14 2013]

Entities: Nancy Morgan, Patient, Sona Mehring

First reported May 13 2013 - Updated May 13 2013 - 1 reports

NeoStem, Inc. (NYSE MKT: NBS), Another PCT agreement

MedStar Georgetown University Hospital in Washington, DC.MedStar Georgetown University Hospital will use the services of PCT for processing and storage of peripheral blood progenitor cells, donor leukocytes, bone marrow and cord blood, as well as requested ... [Published Proactive Investors USA - May 13 2013]

Entities: NeoStem Inc, Georgetown University, New York Stock Exchange, Georgetown Lombardi Comprehensive Cancer Center, Washington DC

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Initiation of Breast Cancer Treatment Varies by Race; Patient-doctor Communication Is Key

WASHINGTON — Black women with breast cancer were found to be three times more likely than their white counterparts to delay treatment for more than 90 days — a time delay associated with increased deaths from the disease, according to a new study led ... [Published ScienceNewsline - May 07 2013]

Entities: Breast Cancer, Georgetown Lombardi Comprehensive Cancer Center

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Initiation of breast cancer treatment varies by race; patient-doctor communication is key

WASHINGTON Black women with breast cancer were found to be three times more likely than their white counterparts to delay treatment for more than 90 days a time delay associated with increased deaths from the disease, according to a new study led by ... [Published EurekAlert! - May 07 2013]

Entities: Breast Cancer, Georgetown Lombardi Comprehensive Cancer Center, Initiation (Cancer), Chemotherapy

First reported Apr 19 2013 - Updated Apr 19 2013 - 1 reports

High-risk screening and high rate of follow up -- patient navigators credited

(NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- WASHINGTON - Low-income and minority women screened for breast cancer at Capital Breast Cancer Center (CBCC) in Washington, DC, exceed national standards in their rate of medical ... [Published NewsRX - Apr 19 2013]

Entities: Navigator, Georgetown Lombardi Comprehensive Cancer Center, Breast Cancer

Quotes

..."We found that cancer cells need a continuous exposure at low concentrations for the drug to be of maximum effectiveness," Toretsky says. "And this strategy works extremely well in these animal models. The drug appears to be very successful."

Preclinical tests shows agent stops 'slippery' proteins from binding, causing Ewing sarcoma [Published FierceBiotech - May 21 2013]

...say additional studies can help understand communication preferences, but until that point they conclude that doctor-patient communications "offer a good leverage point for interventions to improve chemotherapy patterns in black women and ultimately, to reduce race disparities in breast cancer mortality."

Initiation of breast cancer treatment varies by race; patient-doctor communication is key [Published NewsRX - May 17 2013]

...cancer -- had either an EGFR or a KRAS mutation, and results showed that those with EGFR mutations had a very high response to the drug erlotinib. "This is nothing new; we essentially confirmed what was already known" Giaccone says...

First prospective trial shows molecular profiling timely for tailoring therapy [Published Science Daily - May 16 2013]

More Content

sort by: Date \| Relevance
Preclinical tests shows agent stops 'slippery' ... [Published FierceBiotech - May 21 2013]
Regorafenib Appears to Work on All Common Resis... [Published Oncology Times - May 18 2013]
Georgetown Gynecologist Says Expectations of Or... [Published Health Canal - May 17 2013]
Preclinical tests shows agent stops 'slippery' ... [Published National Cancer Institute - May 17 2013]
First prospective trial shows molecular profili... [Published National Cancer Institute - May 17 2013]
Initiation of breast cancer treatment varies by... [Published NewsRX - May 17 2013]
Georgetown Receives PCORI Research Award to Stu... [Published Oncology Business Review - May 17 2013]
First prospective trial shows molecular profili... [Published Science Daily - May 16 2013]
First prospective trial shows molecular profili... [Published Bio-Medicine - May 16 2013]
First prospective trial shows molecular profili... [Published EurekAlert! - May 15 2013]
Preclinical tests shows agent stops 'slippery' ... [Published EurekAlert! - May 15 2013]
Preclinical tests shows agent stops 'slippery' ... [Published Medical Xpress - May 15 2013]
For Breast Cancer,Testing And Surgery Costs Har... [Published WUSA 9 - May 14 2013]
Patient Blogging Could Offer Host of Benefits [Published IHealthBeat - May 14 2013]
NeoStem, Inc. (NYSE MKT: NBS), Another PCT agre... [Published Proactive Investors USA - May 13 2013]
Stem cell therapy another option to Heart trans... [Published KeralaNext.com - May 13 2013]
NeoStem's Subsidiary, Progenitor Cell Therapy, ... [Published Yahoo! Finance - May 13 2013]
Initiation of Breast Cancer Treatment Varies by... [Published ScienceNewsline - May 07 2013]
Initiation of breast cancer treatment varies by... [Published EurekAlert! - May 07 2013]
Still available: 2013 summer internships for h... [Published Examiner.com - Apr 20 2013]
High-risk screening and high rate of follow up ... [Published NewsRX - Apr 19 2013]
Georgetown Univ. and Hackensack Univ. Medical C... [Published PR Newswire: Policy & Public Interest - Apr 09 2013]
Financings of the Fortnight Navigates Sequester... [Published The IN VIVO Blog - Feb 21 2013]
Third Rock Launches Jounce Therapeutics with $47M [Published PE Hub News - Feb 14 2013]
Why is the Importance and Safety of Maternity S... [Published PRWeb - Sep 26 2012]
Social isolation, stress-induced obesity ‘ups b... [Published Topnews.in - Apr 05 2011]
Feverfew Compound May Cut Resistance To Tamoxifen [Published Topnews.in - Feb 17 2010]